Notable Analyst Rating Changes 8/13: MOLX, ULTR, GNLB Upgraded; LVLT, TJX, COMV Downgraded
More News related to ATHN
- Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
- athenahealth to Present at the Jefferies Third Annual Healthcare Conference
- Auriga Initiates Coverage on athenahealth (ATHN) with a Hold; Valuation Seems to Reflect Optimistic Outlook
- Battle Road Research Expands Healthcare Coverage and Launches Blog
- Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower
More News related to COMV
- Comverge, Itron Collaboration Further Advances the Smart Grid
- Comverge (COMV) Names Picchi Interim President, CEO; Dreyer Appointed Chairman; Confirms FY09 Outlook
- Comverge Board Appoints Michael Picchi Interim President and CEO
- Baird Initiates Coverage on Comverge (COMV) with a Neutral
- Comverge Strengthens Commercial & Industrial Demand Response Portfolio
More News related to ELX
- Emulex (ELX) July volatility increases to 83 after Broadcom's raises bid to $11
- Notable Mergers and Acquisitions of the Day 6/30: BRCM/ELX, BPAX/CEGE, PTRY
- Broadcom (BRCM) Raises Offer for Emulex (ELX) to $11
- Emulex Advises Stockholders to Take No Action At This Time in Response to Revised Broadcom Tender Offer
- Broadcom Raises All-Cash Tender Offer for Emulex to $11.00 Per Share
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Credit Suisse upgrades Molex (Nasdaq: MOLX) from Underperform to Neutral with a $26 price target.
UBS upgrades Ultrapertol (Nasdaq: ULTR) from Neutral to Buy. Price target $15.50.
Susquehanna upgrades Genelabs Technologies (NASDAQ: GNLB) to Positive with a $1 price target.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Oppenheimer downgrades Level 3 Communications (Nasdaq: LVLT) from Perform to Underperform, citing economic headlines.
Lazard Capital downgrades TJX Companies (NYSE: TJX) from Buy to Hold.
Goldman Sachs downgrades Comverge, Inc. (Nasdaq: COMV) from Buy to Neutral and cuts its price target to $7.50.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs upgrades Emulex (NYSE: ELX) from Neutral to Buy with a $16.50 price target.
Citi initiates coverage on Toll Bros. (NYSE: TOL) with a Buy. Price target $27.
Thomas Weisel initiates coverage on athenahealth (Nasdaq: ATHN) with an Overweight rating and $40 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-2.09
+17.63Related Entities
- Credit Suisse
- UBS
- Goldman Sachs
- Citi
- Lazard
- Thomas Weisel Partners Group
- Susquehanna International Group of Companies
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
